Form 4: Humana Inc. President & CEO James A. Rechtin Reports Acquisition of Shares and Holdings in Form 4 Filing
SEC Form 4 Filing
James A. Rechtin, President & CEO of Humana Inc., reports the acquisition of shares and holdings of derivative securities in a recent Form 4 filing with the SEC.
Summary
- On February 24, 2025, James A. Rechtin, the President & CEO of Humana Inc., filed a Form 4 with the SEC.
- The filing reports the acquisition of 19,037 Humana Common shares at $0.
- Following the transaction, Rechtin beneficially owns 23,944 shares, including shares held in revocable trusts.
- Rechtin also holds options to acquire 29,230 shares at $458.185, exercisable from January 8, 2025, and options to acquire 15,772 shares at $367.21, exercisable from February 21, 2025.
- Additionally, Rechtin holds 4,366 restricted stock units, which represent a contingent right to receive one share of Humana Inc. common stock each.
- The restricted stock units were granted on January 8, 2024, and vest in three annual increments from January 8, 2025, to January 8, 2027.
- 21,761 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard SEC filing reporting transactions by an insider. The acquisition of shares could be seen as a slightly positive signal, but it's not definitive.
Positives
- The acquisition of shares by the CEO could be interpreted as a positive signal, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. They are closely watched by investors for signals about management's confidence in the company's prospects.
Stakeholder Impact
- The reported transactions provide shareholders with insight into the actions of a key executive.
Key Dates
| Date | Description |
|---|---|
| 01/08/2024 | Restricted stock units granted to reporting person, 33% of the award is vesting on 1/8/25, 1/8/26, and 1/8/27. |
| 01/08/2024 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 1/8/25 to 1/8/27. |
| 02/21/2024 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/21/25 to 2/21/27. |
| 01/08/2025 | First vesting date for options granted on 1/8/2024. |
| 01/08/2025 | First vesting date for restricted stock units granted on 1/8/2024. |
| 02/21/2025 | First vesting date for options granted on 2/21/2024. |
| 02/24/2025 | Date of the reported transaction (acquisition of shares). |
| 02/26/2025 | Date of the Form 4 filing. |
| 01/08/2026 | Second vesting date for options granted on 1/8/2024. |
| 01/08/2026 | Second vesting date for restricted stock units granted on 1/8/2024. |
| 01/08/2027 | Third vesting date for options granted on 1/8/2024. |
| 01/08/2027 | Third vesting date for restricted stock units granted on 1/8/2024. |
| 02/21/2027 | Third vesting date for options granted on 2/21/2024. |
| 01/08/2031 | Expiration date for options granted on 1/8/2024. |
| 02/21/2031 | Expiration date for options granted on 2/21/2024. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.